Stay updated with breaking news from Jin Yi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
åäº«è³ å享è³å¥½ååæåå ä¸å¨çç3天æ¶é´å°±æ2家é¶è¡å¯å¨IPOç³è´ï¼è¿ä¸åºæ¯å·²åä½å¹´æªæ¾åºç°ã éçé½é²é¶è¡ãç丰é¶è¡å åå®ææ°è¡åè¡ï¼Aè¡ä¸å¸é¶è¡æ°éå³å°å¢è³40家ãè¿ä¸å»å¹´å ¨å¹´ä» ä¸åªé¶è¡è¡ç»éAè¡å¸åºç¸æ¯...
据齐鲁银行新股发行结果和中签率公告显示，该行本次股票发行价为5.36元/股，发行数量4.58亿股，中签率为0.12%。 付立春指出，A股IPO目前保持常态化发展，很多新三板挂牌企业均有意转道A股上市。相较于其他挂牌企业，银行的资产规模相对较大，具有持续经营能力，成功登陆A股市场的可预期性相对更强。 另一家在上周完成新股申购的瑞丰银行是一家农商行，不仅是今年A股IPO首家过会的银行，也将在上市后实现浙江省本土农商行A股上...
China Digest: Bloks raises $93m; CareCapital leads $50m funding in Impress May 14, 2021 Shanghai Bloks Technology Group has garnered 600 million yuan ($93 million) in a Series B round of financing, while Barcelona-based novel orthodontics maker Smile2Impress (Impress) has raked in $50 million in its Series A round led by China’s CareCapital. Bloks bags $93m in Series B round Education startup Shanghai Bloks Technology Group has garnered 600 million yuan ($93 million) in a Series B round jointly led by Alibaba co-founder Jack Ma’s YF Fund and existing investor Legend Capital, per an announ...
Chinese biopharma firm DAC Biotech nets $156m co-led by GL Ventures Source: Jan Antonin Kolar/Unsplash May 12, 2021 Biopharmaceutical firm Hangzhou DAC Biotech Co., Ltd has announced the completion of a 1 billion yuan ($156 million) Series C round co-led by PE firm Hillhouse Capital’s venture unit GL Ventures. State-backed CITIC Private Equity Funds Management (CPE), and CDG Capital — a Hong Kong-based investment firm that has invested in healthcare startups like Innovent, Akeso, and Grail — were the co-lead investors, DAC Biotech said in a WeChat post on May 8. It also attracted new...
stevenMay 8, 2021 Silicafumes (CAS 69012-64-2) Market Research Report Offers Insights Into Market Share, Revenue, And Forecast Trends The report on the global Silicafumes (CAS 69012-64-2) market provides all the details regarding the market dynamics and essential aspects of the market. The report provides the entire competitive pipeline in order to gain better insights into the market revenue, key players, share, and regional analysis of the market. The complete overview of the Silicafumes (CAS 69012-64-2) market is provided using research methodologies and primary & secondary sources. In ...